阿司匹林用于动脉粥样硬化性心血管事件的一级预防。

Aspirin for primary prevention of atherosclerotic cardiovascular events.

机构信息

Non-Invasive Cardiovascular Imaging Department, Brigham and Women's Hospital, Boston, MA.

Department of Cardiovascular Medicine; Heart, Vascular, and Thoracic Institute; Director, C5Research (Cleveland Clinic Coordinating Center for Clinical Research); Director, Center for Clinical Research, Lerner Research Institute, Cleveland Clinic; Professor of Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH

出版信息

Cleve Clin J Med. 2020 May;87(5):300-311. doi: 10.3949/ccjm.87a.19045.

DOI:10.3949/ccjm.87a.19045

PMID:32357985

Abstract

Recent trials evaluated the impact of aspirin for primary prevention of cardiovascular events in patients at intermediate risk, patients with diabetes, and the elderly, and the results have been incorporated into the most recent professional guidelines. For the most part, the role of aspirin in primary prevention remains limited, albeit not adequately tested in those at higher risk.

摘要

最近的临床试验评估了阿司匹林在中危患者、糖尿病患者和老年人中的心血管事件一级预防作用，其结果已被纳入最新的专业指南。在大多数情况下，阿司匹林在一级预防中的作用仍然有限，尽管在高危人群中尚未得到充分验证。